<DOC>
	<DOCNO>NCT01533883</DOCNO>
	<brief_summary>Cardioband adjustable annuloplasty band design mitral valve repair transfemoral delivery system . The aim study evaluate performance safety Cardioband repair mitral regurgitation .</brief_summary>
	<brief_title>Cardioband Adjustable Annuloplasty System Minimally Invasive Mitral Valve Repair</brief_title>
	<detailed_description>The current state art management severe mitral regurgitation surgical mitral valve repair , either open chest surgery mini-thoracotomy . However , standard surgical approach require cardiopulmonary bypass reserve fit patient low moderate surgical risk , thus several patient refuse surgery unfavorable risk-benefit balance . Cardioband adjustable annuloplasty band design mitral valve repair transfemoral delivery system . Cardioband intend remodel annulus deployment fixation along ( direct ) posterior annulus mitral valve , order correct mitral regurgitation . Adjustment perform beat heart , optimize correction mitral regurgitation .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Age &gt; 18 year Moderate severe functional MR Symptomatic Patients ( NYHA ClassIIIV ) despite optimal medical therapy , include CRT indicate LVEF ≥ 25 % , LVEDD ≤ 70mm Subject high risk undergo MV surgery ( assessed cardiac surgeon cardiologist site , accord ESC/EACTS guideline management valvular heart disease ) Transseptal catheterization femoral vein access determine feasible Subject able willing give inform consent follow protocol procedure Active bacterial endocarditis Severe organic lesion retract chordae congenital malformation lack valvular tissue Heavily calcify annulus leaflet Subjects transesophageal echocardiography contraindicate Untreated clinically significant CAD requiband revascularization Any percutaneous coronary , carotid , endovascular intervention carotid surgery within 30 day coronary endovascular surgery within 3 month CVA TIA within 6 month severe carotid stenosis ( &gt; 70 % Ultra sound ) Renal insufficiency requiband dialysis Life expectancy less twelve month Patient pregnant ( urine HCG test result positive ) lactate Known sensitivity Nickel Chromium Known hypersensitivity contraindication procedural medication adequately manage medically Bleeding clot disorder Subject participate concomitant research study investigational product Pulmonary hypertension &gt; 70mmHg rest Mitral valve anatomy may preclude proper device treatment Rightsided congestive heart failure echocardiographic evidence severe right ventricular dysfunction severe tricuspid regurgitation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Mitral</keyword>
	<keyword>Valve</keyword>
	<keyword>Annuloplasty</keyword>
	<keyword>Transatrial</keyword>
	<keyword>Transapical</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Mitral valve insufficiency</keyword>
</DOC>